IQVIA Holdings has significantly outperformed the broader S&P 500 Index in recent months, and analysts remain strongly ...

If you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want ...

Over the last decade, the number of cell and gene therapy clinical trials has more than tripled. In this article, several ...

IQVIA and AWS said the collaboration reflects the growing need for cloud-based tools that can support large-scale trial ...

IQVIA (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced a strategic ...

Alliance enables customers to access and deploy validated COA instruments with unprecedented ease and supportHOBOKEN, NJ - Wiley (NYSE: WLY), a global ...

IQVIA (IQV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

IQVIA Market Access Launch Pad is a dynamic and comprehensive suite of tools designed to support pharmaceutical companies in their product launch readiness. It integrates policy structure updates, ...

Detailed price information for Iqvia Holdings Inc (IQV-N) from The Globe and Mail including charting and trades.

With new UK clinical trial rules landing in 2026, the EU Biotech Act on the horizon and China and Australia gaining ground, ...

Biotech and pharma greenhouse gas emissions are falling – but is current progress fast enough? Discover My Green Lab’s Impact ...

The Life Sciences BPO Market is expanding rapidly, driven by rising R&D costs, increasing regulatory complexities and the growing need for operational efficiency across pharma and biotech sectors.